文献速递甲状腺与颈部外科

低生化指标原发性甲状旁腺功能亢进中单腺体与多腺体病变的差异

Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism.
PubMed 文献 · Surgery · 2016-11-12

该单中心回顾性队列研究分析了2006-2012年因原发性甲状旁腺功能亢进接受甲状旁腺切除术的573例患者,比较经典、正常激素性和正常血钙性三种生化类型的差异。发现正常血钙性患者多腺体病变发生率显著高于其他两组,而正常激素性患者以单腺瘤为主,三组术后12个月生化正常化率均超过98%。

要点

  • 正常血钙性原发性甲状旁腺功能亢进多腺体病变发生率高达45%。
  • 正常激素性患者多腺体病变仅10%,与经典组9%相似。
  • 三组术后12个月生化正常化率均超过98%。

核心结论

  • 正常血钙性原发性甲状旁腺功能亢进与多腺体病变高发相关。
  • 正常激素性疾病与经典疾病相似,超过90%表现为单腺瘤。
  • 三种生化类型患者手术治疗均可获得极好的生化正常化率。

研究设计与样本

  • 单中心回顾性队列研究,纳入2006-2012年因原发性甲状旁腺功能亢进接受甲状旁腺切除术的患者共573例。
  • 分组:经典组405例,正常激素性组96例,正常血钙性组72例。
  • 分析术前和术中变量,采用方差分析和χ2检验进行单变量分析,Logistic回归识别多腺体病变的独立预测因素。

主要发现

  • 正常血钙性组多腺体病变43例(45%),显著高于正常激素性组7例(10%)和经典组36例(9%),P < .001。
  • Logistic回归显示正常血钙性亚型和阳性家族史是多腺体病变的显著预测因素。
  • 术后12个月生化正常化率在三组中均超过98%。

关键数值与推荐

  • 正常血钙性组多腺体病变发生率45%(43/72),正常激素性组10%(7/96),经典组9%(36/405),P < .001。
  • 术后12个月生化正常化率三组均超过98%。

临床怎么用

  • 对正常血钙性原发性甲状旁腺功能亢进患者,术前应警惕多腺体病变可能,术中探查需更全面。
  • 正常激素性患者表现类似经典疾病,多数为单腺瘤,可按经典疾病策略处理。
  • 三种类型患者均可通过手术获得高比例生化正常化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Primary hyperparathyroidism is characterized by increased levels of serum calcium and parathyroid hormone. Recently, 2 additional mild biochemical profiles have emerged, normocalcemic and normohormonal primary hyperparathyroidism. We reviewed our surgical experience of mild biochemical profile patients and compared them with classic primary hyperparathyroidism patients. METHODS: This is a single institution, retrospective cohort review of all patients who underwent parathyroidectomy for primary hyperparathyroidism from 2006-2012. Preoperative and intraoperative variables were analyzed. Univariable analysis was performed with analysis of variance and the χ2 test. A logistic regression was performed to identify significantly independent predictor variables for multigland disease. RESULTS: A total of 573 patients underwent parathyroidectomy for primary hyperparathyroidism (classic, n = 405; normohormonal, n = 96; normocalcemic, n = 72). Normocalcemic primary hyperparathyroidism was associated with multigland disease in 43 (45%, P < .001) patients as compared with the normohormonal (7, 10%) and classic (36, 9%) groups. On logistic regression, significant predictors for multigland disease were the normocalcemic subtype and positive family history. Twelve month biochemical normalization rates after operative treatment were >98% in all 3 groups. CONCLUSION: Our series shows that normocalcemic primary hyperparathyroidism is associated with a high incidence of multigland disease. Normohormonal disease is similar to classic disease patients with >90% presenting with single adenomas. Excellent rates of biochemical normalization can be obtained by operative treatment in all 3 groups.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Lim JY, Herman MC, Bubis L, et al. Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism. Surgery. 2016. PMID: 27847113. doi:10.1016/j.surg.2016.08.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。